PMA supplement
N18033 S024: ACUVUE(R) (ETAFILICON A) HYDROPHILIC CONTACT LENS
FDA PMA supplement · Normal 180 Day Track · Vistakon, Johnson & Johnson Vision Products, Inc.
Key facts
| Original PMA | N18033 |
|---|---|
| Supplement number | S024 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | ACUVUE(R) (ETAFILICON A) HYDROPHILIC CONTACT LENS |
| Generic name | Lenses, soft contact, daily wear |
| Applicant | Vistakon, Johnson & Johnson Vision Products, Inc. |
| Product code | LPL |
| Received date | Jun 5, 1990 |
| Decision date | Oct 27, 1993 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: